BIOMAT Database Logo BIOMAT Database Logo

[Low-dose cytosine arabinoside treatment in acute myeloid leukemia]. 1984

M K Jensen, and G Ahlbom, and O F Leegaard

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

M K Jensen, and G Ahlbom, and O F Leegaard
[Low-dose cytosine arabinoside (ARA-C) in the treatment of acute myeloid leukemia].
December 1984, Schweizerische medizinische Wochenschrift,
M K Jensen, and G Ahlbom, and O F Leegaard
[Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside].
October 1994, Ugeskrift for laeger,
M K Jensen, and G Ahlbom, and O F Leegaard
Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose cytosine arabinoside.
January 1985, Haematology and blood transfusion,
M K Jensen, and G Ahlbom, and O F Leegaard
Low dose cytosine arabinoside therapy in myelodysplastic syndrome and acute myeloid leukemia.
June 1987, Japanese journal of clinical oncology,
M K Jensen, and G Ahlbom, and O F Leegaard
Different response rates to low-dose cytosine arabinoside in acute myeloid leukemia subtypes.
June 1987, Seminars in oncology,
M K Jensen, and G Ahlbom, and O F Leegaard
Low-dose cytosine arabinoside in the treatment of acute nonlymphocytic leukemia.
January 1988, Acta haematologica,
M K Jensen, and G Ahlbom, and O F Leegaard
Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone.
June 1987, Seminars in oncology,
M K Jensen, and G Ahlbom, and O F Leegaard
Low-dose cytosine arabinoside in relapsed acute lymphocytic leukemia.
January 1990, The American journal of medicine,
M K Jensen, and G Ahlbom, and O F Leegaard
Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia.
February 1989, Cancer,
M K Jensen, and G Ahlbom, and O F Leegaard
Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
April 1984, Blut,
Copied contents to your clipboard!